BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10071596)

  • 1. Hepatic artery administration of paclitaxel.
    Walton GD; Schreeder MT; Rizzo J; Jobe DR; Kuhn J
    Cancer Invest; 1999; 17(2):118-20. PubMed ID: 10071596
    [No Abstract]   [Full Text] [Related]  

  • 2. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.
    Ettinger DS
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):148-50. PubMed ID: 10210554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
    Edelman MJ; Chansky K; Gaspar LE; Leigh B; Weiss GR; Taylor SA; Crowley J; Livingston R; Gandara DR
    J Clin Oncol; 2004 Jan; 22(1):127-32. PubMed ID: 14701775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Morrissey LH; Scullin DC; Houston GA; Prasthofer EF; Gray JR; Burris HA; Greco FA
    Cancer; 2002 May; 94(9):2426-33. PubMed ID: 12033195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous prophylaxis for paclitaxel-related hypersensitivity reactions.
    Bookman MA; Kloth DD; Kover PE; Smolinski S; Ozols RF
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-13-S19-15. PubMed ID: 9427258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of intra-arterial infusion chemotherapy in small cell lung cancer with liver metastases].
    Fujii S; Nakajima K; Ueno K; Sugai Y; Adachi M
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3627-30. PubMed ID: 2554817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia.
    Rapp JS; Perry MC; Rotche RM
    Semin Oncol; 1996 Apr; 23(2):xv-xxii; discussion xxii. PubMed ID: 8623054
    [No Abstract]   [Full Text] [Related]  

  • 8. Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient.
    Kaira K; Ishizuka T; Yanagitani N; Sunaga N; Hisada T; Mori M
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):225-7. PubMed ID: 17301532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small cell lung cancer: phase I study.
    Endo M; Takada Y; Obayashi K; Kotani Y; Satouchi M; Kado T; Sugimura K
    Radiat Med; 2005 Aug; 23(5):331-5. PubMed ID: 16342905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
    J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily paclitaxel and thoracic radiation therapy for non-small cell lung cancer: preliminary results.
    Rathmann J; Leopold KA; Rigas JR
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):130-5. PubMed ID: 10210552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
    Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
    Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.
    Greco FA; Thompson DS; Morrissey LH; Erland JB; Burris HA; Spigel DR; Joseph G; Corso SW; Spremulli E; Hainsworth JD
    Oncologist; 2005 Oct; 10(9):728-33. PubMed ID: 16249353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):60-6. PubMed ID: 10190785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer.
    Mori K; Kamiyama Y; Kondo T; Kano Y; Kodama T
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):86-90. PubMed ID: 16447041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
    Socinski MA; Schell MJ; Bakri K; Peterman A; Lee JH; Unger P; Yates S; Hudgens S; Kies MS
    Cancer; 2002 Sep; 95(6):1265-73. PubMed ID: 12216094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
    J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.
    Camacho LH; Kurzrock R; Cheung A; Barber DF; Gupta S; Madoff DC; Wallace MJ; Kim EE; Curley SA; Hortobagyi GN; Mavligit G
    Cancer; 2007 Jun; 109(11):2190-6. PubMed ID: 17464952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nogitecan hydrochloride].
    Negoro S
    Nihon Rinsho; 2002 May; 60 Suppl 5():370-3. PubMed ID: 12101691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.